Menu
Recruiting NCT06551766

The Application of Photosensitive Hydrogel in Intranasal Endoscopic Dacryocystorhinostomy

No phase Interventional Chronic Dacryocystitis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Photosensitive hydrogel, 6-0 absorbable stitches.
Who it may be relevant to
Registry conditions: Chronic Dacryocystitis. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Application of Photosensitive Hydrogel in Intranasal Endoscopic Dacryocystorhinostomy for the Anastomosis of Lacrimal Cyst Flap and Nasal Mucoperiosteal Flap

Overview

To study the effect of Photosensitive hydrogel used for suture free anastomosis of lacrimal cyst and nasal mucoperiosteal flap in endoscopic nasal dacryocystostomy, and evaluate its adhesion to lacrimal cyst and nasal mucoperiosteal flap, promoting wound healing, forming a good anastomosis, preventing postoperative anastomosis and shortening operation time. Twenty patients with chronic dacryocystitis were randomly divided into photosensitive hydrogel group and suture group.Symptoms and nasal endoscopy were followed up 2, 6, and 12 weeks after surgery for both groups. And also adverse events were recorded at each follow-up.

Detailed description

After endoscopic dacryocystonasal anastomosis, granulation and/or cicatricial adhesion are the main reasons for surgical failure. How to achieve the ideal fit between the lacrimal sac flap and the nasal mucoperiosteal flap and avoid the proliferation of granulation and cicatricial adhesion is very important for the success of the operation. In this study, "photocoupling reaction" technology was used to achieve seamless integration and strong adhesion of photosensitive hydrogel materials to the wound, and the photohydrogel was applied to suture free adhesion and wound repair of the lacrimal cyst mucosal flap and nasal mucosal flap in endoscopic nasal Dacryocystostomy (En-DCR), and its feasibility, safety and effectiveness were evaluated.

Interventions

  • Device Photosensitive hydrogel
    In the photosensitive hydrogel group, the anastomosis of the lacrimal cyst mucosal flap and the nasal mucoperiosteal flap was achieved by photosensitive hydrogel.
  • Device 6-0 absorbable stitches
    In the suture fixation group, the anastomosis of the lacrimal cyst mucosal flap and the nasal mucoperiosteal flap was achieved by two stitches using 6-0 absorbable wire.

Primary outcome measures

  • Anastomotic opening rate [Time frame: 6 weeks after surgery]
Secondary outcome measures (1)
  • Remission rate of tearing symptoms [Time frame: 2, 6 and 12 weeks after surgery]

Eligibility criteria

Inclusion criteria

  • Voluntarily participate in this clinical study and sign the informed consent;
  • Gender is not limited, age 18-75 years old;
  • The patient had symptoms and signs of chronic dacryocystitis, and the results of lacrimal passage irrigation suggested that the lower rush and return or upper rush and lower return, accompanied by mucous or purulent discharge reflux;
  • Lacrimal duct angiography suggests nasolacrimal duct obstruction without lacrimal canaliculi and/or duct obstruction.

Exclusion criteria

  • Age < 18 or > 75 years old;
  • Previous history of dacryocystonasal anastomosis;
  • Abnormal coagulation function;
  • Tumors of lacrimal passage, especially in patients with papilloma or malignant tumors;
  • in the acute dacryocystitis attack stage;
  • obvious scar constitution;
  • Complicated with serious nasal diseases, such as severe allergic rhinitis, chronic rhinosinusitis and nasal polyps, acute suppurative rhinosinusitis, severe atrophic rhinitis, and severe deviation of nasal septum;
  • Have serious heart, liver, kidney, lung and other basic diseases, can not tolerate general anesthesia;
  • Distance from the hospital, postoperative review is not convenient;
  • Participated in other clinical trials within the last 3 months;
  • Any medical history that the investigator determines may interfere with the test results or increase the patient's risk.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

China · 1 center
  • Eye & ENT Hospital of Fudan University — Shanghai

Identifiers

NCT: NCT06551766 · 2023017

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗